Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Operating Expenses (2016 - 2021)

Historic Operating Expenses for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to $3.1 million.

  • ENDRA Life Sciences' Operating Expenses rose 3625.0% to $3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $11.5 million, marking a year-over-year decrease of 3.14%. This contributed to the annual value of $10.8 million for FY2024, which is 281.74% up from last year.
  • Latest data reveals that ENDRA Life Sciences reported Operating Expenses of $3.1 million as of Q4 2021, which was up 3625.0% from $2.7 million recorded in Q3 2021.
  • Over the past 5 years, ENDRA Life Sciences' Operating Expenses peaked at $3.3 million during Q3 2020, and registered a low of $360697.0 during Q1 2017.
  • Moreover, its 5-year median value for Operating Expenses was $2.6 million (2019), whereas its average is $2.4 million.
  • As far as peak fluctuations go, ENDRA Life Sciences' Operating Expenses soared by 68841.58% in 2018, and later crashed by 2799.16% in 2020.
  • ENDRA Life Sciences' Operating Expenses (Quarter) stood at $2.3 million in 2017, then fell by 12.93% to $2.0 million in 2018, then skyrocketed by 56.31% to $3.1 million in 2019, then fell by 27.99% to $2.3 million in 2020, then soared by 36.25% to $3.1 million in 2021.
  • Its last three reported values are $3.1 million in Q4 2021, $2.7 million for Q3 2021, and $3.2 million during Q2 2021.